Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Tuberculosis (TB) resistance to rifampicin, the most powerful drug leads to increase in mortality. Globally, half a million new patients develop such resistant TB each year, coupled with both inappropriate diagnosis and treatment initiation.We report a case of rifampicin resistant Mycobacterium tube...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Willy Ssengooba, Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Winceslaus Katagira, Ivan Kimuli, Moses L Joloba, Susan Adakun, Lydia Nakiyingi, Gabriela Torrea, Bruce J Kirenga
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
XpertMTB/RIF
G4
ULTRA
Rifampicin
Discordance
Diseases of the respiratory system
RC705-779
Infectious and parasitic diseases
RC109-216
Acceso en línea:https://doaj.org/article/2089ea3e49994b73aa467bc594eb9ba4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/2089ea3e49994b73aa467bc594eb9ba4

Ejemplares similares